Novonesis A/s Class B · OMXCOP:NSIS_B

Novonesis A/s Class B — Novozymes — 9M 2016 Earnings Presentation

10 slides from Novonesis A/s Class B's earnings presentation, Oct 26, 2016

  1. Slide 1: Conference call 9M 2016

    Conference call 9M 2016 ​October 26, 2016

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements ​This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limited to, "be

  3. Slide 3: 9M 2016 summary

    9M 2016 summary ​9M sales lower than expected; EBIT & EBIT margin are Sales and organic growth 9M 2014 – 9M 2016 on par with last year DKKm 10% 8% 11.000 • 1% organic sales growth and -1% in DKK in the first 9 months of 2016. 8% 10.500 Growth driven by Household Care, F&B and Technical & Pharma 6% 4

  4. Slide 4: Household Care & Technical

    Household Care & Technical +1% / 0% Organic growth / DKK growth Household Care • Continued strong momentum in China and South East Asia, driven by increased penetration in liquid detergents. Growth offset by 3.484 3.484 weaker performance in Europe • Premium detergents still in demand in North Ameri

  5. Slide 5: Hygiene solutions to deliver the next wave of growth for laundry

    Hygiene solutions to deliver the next wave of growth for laundry in both developed and emerging markets Four key trends are increasing consumers’ Novozymes invests to ensure innovative, safe and natural laundry hygiene concerns solutions to address consumers’ hygiene concerns 1 ​Traditional enzyme s

  6. Slide 6: Agriculture & Bioenergy

    Agriculture & Bioenergy Organic growth / DKK growth ​Bioenergy • U.S. ethanol producers’ margins remain low, and producers are continuing their optimization programs and cost reductions, resulting in further downtrading -7% / -8 % 0% / -5% • Avantec® Amp progressing better, but uptake still slower t

  7. Slide 7: Food & Beverages

    Food & Beverages Organic growth / DKK growth ​Baking +1% / 0% • Baking marginally below last year, as good growth in Europe and Asia-Pacific was outweighed by increasing competition in the Americas ​Starch 2.815 2.802 • Solid growth in starch driven by increasing penetration across markets and appli

  8. Slide 8: Research & Innovation update

    Research & Innovation update Acquisition of Organo Balance Innovation Strengthening our microbial platform ​Exciting new launches expected in Q4 • Germany-based Organo Balance will be integrated as • SAT B-300 – new upstream inoculant to be part of Novozymes’ global R&D organization, enhancing launc

  9. Slide 9: Financial performance & outlook

    Financial performance & outlook ​9M 2016: Earnings on par with last year Key Realized 2016 outlook financials 9M 2016 October 26 • Gross margin roughly on par with last year, as productivity improvements offset the one-time reorganization cost incurred in Q1 Sales growth, org. +1% ~2% • Adjusting fo

  10. Slide 10: Novozymes – Rethink Tomorrow

    x novozymes’ Rethink Tomorrow

Novozymes — 9M 2016 Earnings Presentation on 6ix